Literature DB >> 1581911

Persistent clonal areas and clonal expansion in Barrett's esophagus.

W H Raskind1, T Norwood, D S Levine, R C Haggitt, P S Rabinovitch, B J Reid.   

Abstract

Three patients with Barrett's esophagus who had cytogenetic abnormalities detected in their metaplastic epithelium developed high-grade dysplasia or adenocarcinoma during prospective surveillance over a period of 1.5 to 6 years. In the 3 cases, cytogenetic abnormalities that were associated with the most advanced histological lesions were present in samples obtained 11, 25, and 48 months prior to the diagnosis of high-grade dysplasia or carcinoma. In a fourth patient, marker chromosomes found in a Barrett's adenocarcinoma were also present in an esophageal region spatially removed from the tumor. In all four patients, clonal cytogenetic abnormalities were present in samples obtained at widespread locations in the Barrett's segment. These observations suggest that in some patients with Barrett's esophagus clonal proliferations arise in regions of benign histology and spread to involve large areas of Barrett's mucosa. These clones persisted when the disease progressed to high-grade dysplasia or adenocarcinoma.

Entities:  

Mesh:

Year:  1992        PMID: 1581911

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

Review 1.  Molecular biology of Barrett's adenocarcinoma.

Authors:  B P Wijnhoven; H W Tilanus; W N Dinjens
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

Review 2.  Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.

Authors:  J A Jankowski; N A Wright; S J Meltzer; G Triadafilopoulos; K Geboes; A G Casson; D Kerr; L S Young
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

Review 3.  Early events during neoplastic progression in Barrett's esophagus.

Authors:  Brian J Reid
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

4.  Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma.

Authors:  Nishant Agrawal; Yuchen Jiao; Chetan Bettegowda; Susan M Hutfless; Yuxuan Wang; Stefan David; Yulan Cheng; William S Twaddell; Nyan L Latt; Eun J Shin; Li-Dong Wang; Liang Wang; Wancai Yang; Victor E Velculescu; Bert Vogelstein; Nickolas Papadopoulos; Kenneth W Kinzler; Stephen J Meltzer
Journal:  Cancer Discov       Date:  2012-08-09       Impact factor: 39.397

5.  Residual embryonic cells as precursors of a Barrett's-like metaplasia.

Authors:  Xia Wang; Hong Ouyang; Yusuke Yamamoto; Pooja Ashok Kumar; Tay Seok Wei; Rania Dagher; Matthew Vincent; Xin Lu; Andrew M Bellizzi; Khek Yu Ho; Christopher P Crum; Wa Xian; Frank McKeon
Journal:  Cell       Date:  2011-06-24       Impact factor: 41.582

6.  LINE-1 expression and retrotransposition in Barrett's esophagus and esophageal carcinoma.

Authors:  Tara T Doucet-O'Hare; Nemanja Rodić; Reema Sharma; Isha Darbari; Gabriela Abril; Jungbin A Choi; Ji Young Ahn; Yulan Cheng; Robert A Anders; Kathleen H Burns; Stephen J Meltzer; Haig H Kazazian
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

Review 7.  Barrett's esophagus: model of neoplastic progression.

Authors:  Stig Ramel
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

8.  Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma.

Authors:  P L Blount; S J Meltzer; J Yin; Y Huang; M J Krasna; B J Reid
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

Review 9.  Barrett's oesophagus: an ideal model to study cancer genetics.

Authors:  Massimiliano di Pietro; Rebecca C Fitzgerald
Journal:  Hum Genet       Date:  2009-04-14       Impact factor: 4.132

10.  Hybrid Stomach-Intestinal Chromatin States Underlie Human Barrett's Metaplasia.

Authors:  Harshabad Singh; Kyungsik Ha; Jason L Hornick; Shariq Madha; Paloma Cejas; Kunal Jajoo; Pratik Singh; Paz Polak; Hwajin Lee; Ramesh A Shivdasani
Journal:  Gastroenterology       Date:  2021-06-04       Impact factor: 33.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.